mRNA Biology Modulators Pipeline

Anima's wholly owned disclosed pipeline of mRNA biology modulators is in Immunology (Lung fibrosis candidate advancing in preclinical stage), in Oncology (Solid tumors lead compounds entering preclinical stage and additional programs against Lymphoma and Neuroblastoma), in Neuroscience (Alzheimer's disease and Pain).

In addition to our own pipeline, we established strategic collaborations with Pharma in partnered programs including our collaborations with Lilly, Takeda Pharmaceuticals, and Abbvie.

Indication   Target
Discovery
Optimization
Preclinical
Immunology
Lung fibrosis   1
Multiple fibrosis 2
Multiple fibrosis 3
Undisclosed abbvie logo 4
Oncology
Solid tumors   5
Solid tumors 6
Leukemia 7
Neuroblastoma   8
Solid tumors   9
Undisclosed abbvie logo 10
Undisclosed 11
Neuroscience
Alzheimer   12
Pain   13
Undisclosed 14
Undisclosed takeda logo 15
Undisclosed 16
Huntington   17
Undisclosed lilly logo 18
Undisclosed 19
Undisclosed 20
Area Indication Target
Discovery
Optimization
Preclinical
Immunology Lung fibrosis 1
Multiple fibrosis 2
Multiple fibrosis 3
Undisclosed abbvie logo 4
Oncology Solid tumors 5
Solid tumors 6
Leukemia 7
Neuroblastoma 8
Solid tumors 9
Undisclosed abbvie logo 10
Undisclosed 11
Neuroscience Alzheimer   12
Pain   13
Undisclosed   14
Undisclosed takeda logo 15
Undisclosed 16
Huntington   17
Undisclosed lilly logo 18
Undisclosed 19
Undisclosed 20